{"id":67551,"date":"2026-06-29T09:48:48","date_gmt":"2026-06-29T04:18:48","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=67551"},"modified":"2026-06-29T09:48:49","modified_gmt":"2026-06-29T04:18:49","slug":"importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/","title":{"rendered":"Importance of hs-CRP as a risk assessment tool for cardiovascular disease"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/iuGIJvY4jYE?si=VtwDYzcS3IVciomx\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">Atherosclerosis is no longer viewed strictly as a lipid related disease; it is fundamentally an inflammatory process. High-sensitivity C-reactive protein (hs-CRP) has emerged as the most clinically validated biomarker to capture this inflammatory risk, serving as a critical tiebreaker in primary prevention and risk stratification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Here is how hs-CRP fits into current clinical practice, pathophysiology, and patient management.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The Inflammatory Pathophysiology<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">While LDL cholesterol initiates subendothelial injury, inflammation drives plaque progression and instability, the inflammatory cascade begins with interleukins (primarily IL-1\u03b2 and IL-6), which stimulate the liver to produce CRP.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Elevated hs-CRP indicates active macrophage infiltration within the arterial wall and the localized secretion of matrix metalloproteinases, which thin the fibrous cap. Therefore, hs-CRP is not just a marker of plaque <em>burden<\/em>; it is a marker of plaque <em>vulnerability<\/em> and impending atherothrombosis.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical Utility: Risk Reclassification<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The primary value of hs-CRP lies in risk reclassification for patients where the decision to initiate statin therapy is ambiguous.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the ACC\/AHA guidelines, an hs-CRP level of \u2265 2.0 mg\/L is officially classified as a <strong>risk-enhancing factor<\/strong>.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Low Risk (&lt; 5% ASCVD) or High Risk (\u2265 20% ASCVD):<\/strong> hs-CRP rarely changes management, as the treatment path is already clear.<\/li>\n\n\n\n<li class=\"\"><strong>Borderline (5% to &lt; 7.5%) or Intermediate Risk (7.5% to &lt; 20%):<\/strong> A repeatedly elevated hs-CRP strongly favors the initiation of moderate-to-high intensity statin therapy.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tools like the <strong>Reynolds Risk Score<\/strong> directly incorporate hs-CRP alongside family history to reclassify patients. This often identifies high-risk individuals\u2014particularly women\u2014who are frequently missed or underscored by standard lipid-centric calculators.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Key insight:<\/strong> Statins possess pleiotropic effects, meaning they lower hs-CRP independent of their LDL-lowering capabilities. Tracking both parameters allows you to monitor both the lipid and the inflammatory response to therapy.<\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">Landmark Clinical Trials<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Two pivotal trials established the clinical mandate for evaluating and targeting inflammation:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Trial<\/strong><\/td><td><strong>Hypothesis<\/strong><\/td><td><strong>Key Finding<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>JUPITER (2008)<\/strong><\/td><td>Do statins benefit patients with LDL <130 mg\/dL, but high inflammation?<\/td><td>Rosuvastatin reduced major adverse cardiovascular events (MACE) by 44% in patients with LDL &lt; 130 mg\/dL but hs-CRP \u2265 2.0 mg\/L.<\/td><\/tr><tr><td><strong>CANTOS (2017)<\/strong><\/td><td>Does targeting inflammation directly (without lowering LDL) reduce risk?<\/td><td>Canakinumab (IL-1\u03b2 inhibitor) significantly reduced MACE, proving the &#8220;inflammatory hypothesis&#8221; of cardiovascular disease.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Practical Measurement Considerations<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Because CRP is an acute-phase reactant, it lacks specificity. To use it effectively for cardiovascular risk assessment:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Timing:<\/strong> It must be measured in a metabolically stable state, free of acute infection, trauma, or active illness.<\/li>\n\n\n\n<li class=\"\"><strong>Confirmation:<\/strong> A single elevated reading is insufficient. Guidelines recommend two measurements taken at least two weeks apart, using the lower of the two values to guide therapy.<\/li>\n\n\n\n<li class=\"\"><strong>Extreme Elevations:<\/strong> Values &gt; 10 mg\/L usually indicate an acute systemic infection or an active rheumatologic flare, rather than baseline cardiovascular risk. These results should prompt an evaluation for non-cardiovascular causes.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">References<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">JUPITER Trial (2008)<sup><\/sup><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin<\/em><sup><\/sup><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Article:<\/strong> Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein<\/li>\n\n\n\n<li class=\"\"><strong>Authors:<\/strong> Paul M. Ridker, Eleanor Danielson, Francisco A.H. Fonseca, et al.<\/li>\n\n\n\n<li class=\"\"><strong>Journal:<\/strong> <em>New England Journal of Medicine<\/em><\/li>\n\n\n\n<li class=\"\"><strong>Citation:<\/strong> N Engl J Med 2008; 359:2195-2207<\/li>\n\n\n\n<li class=\"\"><strong>DOI:<\/strong> <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa0807646\" target=\"_blank\" rel=\"noreferrer noopener\">10.1056\/NEJMoa0807646<\/a><\/li>\n\n\n\n<li class=\"\"><strong>Direct NEJM Link:<\/strong> <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa0807646\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa0807646<\/a><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">CANTOS Trial (2017)<sup><\/sup><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Canakinumab Anti-inflammatory Thrombosis Outcomes Study<\/em><sup><\/sup><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Article:<\/strong> Anti-inflammatory Therapy with Canakinumab for Atherosclerotic Disease<\/li>\n\n\n\n<li class=\"\"><strong>Authors:<\/strong> Paul M. Ridker, Jean G. MacFadyen, Wolfgang Koenig, et al.<\/li>\n\n\n\n<li class=\"\"><strong>Journal:<\/strong> <em>New England Journal of Medicine<\/em><\/li>\n\n\n\n<li class=\"\"><strong>Citation:<\/strong> N Engl J Med 2017; 377:1119-1131<\/li>\n\n\n\n<li class=\"\"><strong>DOI:<\/strong> <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa1707914\" target=\"_blank\" rel=\"noreferrer noopener\">10.1056\/NEJMoa1707914<\/a><\/li>\n\n\n\n<li class=\"\"><strong>Direct NEJM Link:<\/strong> <a href=\"https:\/\/www.google.com\/search?q=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa1707914\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1707914<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Atherosclerosis is no longer viewed strictly as a lipid related disease; it is fundamentally an inflammatory process. High-sensitivity C-reactive protein (hs-CRP) has emerged as the most clinically validated biomarker to capture this inflammatory risk, serving as a critical tiebreaker in primary prevention and risk stratification. Here is how hs-CRP fits into current clinical practice, pathophysiology, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67552,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-67551","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Importance of hs-CRP as a risk assessment tool for cardiovascular disease - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Importance of hs-CRP as a risk assessment tool for cardiovascular disease - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Atherosclerosis is no longer viewed strictly as a lipid related disease; it is fundamentally an inflammatory process. High-sensitivity C-reactive protein (hs-CRP) has emerged as the most clinically validated biomarker to capture this inflammatory risk, serving as a critical tiebreaker in primary prevention and risk stratification. Here is how hs-CRP fits into current clinical practice, pathophysiology, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T04:18:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T04:18:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1279\" \/>\n\t<meta property=\"og:image:height\" content=\"715\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Importance of hs-CRP as a risk assessment tool for cardiovascular disease\",\"datePublished\":\"2026-06-29T04:18:48+00:00\",\"dateModified\":\"2026-06-29T04:18:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/\"},\"wordCount\":314,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/\",\"name\":\"Importance of hs-CRP as a risk assessment tool for cardiovascular disease - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg\",\"datePublished\":\"2026-06-29T04:18:48+00:00\",\"dateModified\":\"2026-06-29T04:18:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg\",\"width\":1279,\"height\":715},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Importance of hs-CRP as a risk assessment tool for cardiovascular disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Importance of hs-CRP as a risk assessment tool for cardiovascular disease - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/","og_locale":"en_US","og_type":"article","og_title":"Importance of hs-CRP as a risk assessment tool for cardiovascular disease - All About Cardiovascular System and Disorders","og_description":"Atherosclerosis is no longer viewed strictly as a lipid related disease; it is fundamentally an inflammatory process. High-sensitivity C-reactive protein (hs-CRP) has emerged as the most clinically validated biomarker to capture this inflammatory risk, serving as a critical tiebreaker in primary prevention and risk stratification. Here is how hs-CRP fits into current clinical practice, pathophysiology, [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-06-29T04:18:48+00:00","article_modified_time":"2026-06-29T04:18:49+00:00","og_image":[{"width":1279,"height":715,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Importance of hs-CRP as a risk assessment tool for cardiovascular disease","datePublished":"2026-06-29T04:18:48+00:00","dateModified":"2026-06-29T04:18:49+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/"},"wordCount":314,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/","url":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/","name":"Importance of hs-CRP as a risk assessment tool for cardiovascular disease - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg","datePublished":"2026-06-29T04:18:48+00:00","dateModified":"2026-06-29T04:18:49+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Importance-of-hs-CRP-as-a-risk-assessment-tool-for-cardiovascular-disease.jpg","width":1279,"height":715},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/importance-of-hs-crp-as-a-risk-assessment-tool-for-cardiovascular-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Importance of hs-CRP as a risk assessment tool for cardiovascular disease"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=67551"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67551\/revisions"}],"predecessor-version":[{"id":67559,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67551\/revisions\/67559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/67552"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=67551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=67551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=67551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}